Provided by Tiger Trade Technology Pte. Ltd.

22nd Century

3.01
-0.6736-18.29%
Pre-market: 3.200.1900+6.31%04:17 EDT
Volume:99.74K
Turnover:341.08K
Market Cap:2.15M
PE:-0.01
High:3.71
Open:3.71
Low:3.00
Close:3.68
52wk High:646.50
52wk Low:3.00
Shares:714.00K
Float Shares:679.40K
Volume Ratio:9.76
T/O Rate:14.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-501.1176
EPS(LYR):-3,479.2885
ROE:-105.72%
ROA:-30.95%
PB:0.12
PE(LYR):0.00

Loading ...

22nd Century faces contract termination, seeks new manufacturing opportunities

TIPRANKS
·
Jul 03

22nd Century Group - to Cease Manufacturing for Smoker Friendly International After Termination Period - SEC Filing

THOMSON REUTERS
·
Jul 03

22nd Century files to sell 3.02M shares of common stock for holders

TIPRANKS
·
Jun 13

22nd Century trading halted, news pending

TIPRANKS
·
Jun 12

22nd Century Shareholders Back Board, Pay and Auditor Plans

TIPRANKS
·
Jun 12

22nd Century Group shareholders re-elect Lucille Salhany to board at annual meeting

Reuters
·
Jun 12

22nd Century corrects inducement warrant exercise price to $3.57 in amended filing

Reuters
·
Jun 09

22nd Century Announces Reverse Split and Warrant Inducement

TIPRANKS
·
Jun 09

22nd Century Group launches warrant inducement, issues new warrants at $0.46 exercise price

Reuters
·
Jun 09

22nd Century Group launches Pinnacle VLN reduced-nicotine cigarette trial in California

Reuters
·
May 21

22nd Century Group (Nasdaq: XXII) Expands High-Margin Pinnacle Platform With Launch of Pinnacle Pure at Major U.S. Retailers

GlobeNewswire
·
May 18

22nd Century Group expands Pinnacle VLN cigarette distribution to nearly 150 metro NY-NJ stores

Reuters
·
May 15

22nd Century Group (Nasdaq: XXII) Ignites Major VLN® Retail Expansion in Metro New York and Northern New Jersey Under Pinnacle Brand

GlobeNewswire
·
May 15

FDA accepts 22nd Century VLN cigarette MRTP renewals for scientific review

Reuters
·
May 13

22Nd Century Group, Inc. Highlights FDA Filing of Vln® Mrtp Renewal Applications for Scientific Review

THOMSON REUTERS
·
May 13

FDA: Filed Two Modified Risk Tobacco Product Renewal Applications for Scientific Review From 22Nd Century Group

THOMSON REUTERS
·
May 12

22nd Century Q1 FY26 operating loss widens to $3.04 million; revenue falls 31.1% to $4.1 million

Reuters
·
May 07

22nd Century Group Q1 EPS $(5.07) Misses $(4.20) Estimate, Sales $4.105M Miss $4.610M Estimate

Benzinga Earnings
·
May 07

22Nd Century Group Inc - Q1 Net Revenues Increase to $4.1 Mln From $3.5 Mln

THOMSON REUTERS
·
May 07

22Nd Century Group Inc: Q1 EPS From Cont Ops $-5.07

THOMSON REUTERS
·
May 07